Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 18, 2023, Alan M. Lotvin, M.D., Executive Vice President and President, Pharmacy Services, advised CVS Health Corporation of his intention to retire in April 2023.

Item 7.01 Regulation FD Disclosure.

On January 23, 2023, CVS Health Corporation announced that it has appointed J. David Joyner as its new President, Pharmacy Services, effective January 30, 2023.

On January 23, 2023, CVS Health Corporation issued a press release announcing Dr. Lotvin's retirement, described in Item 5.02 above, and Mr. Joyner's appointment. A copy of that press release is furnished herewith as Exhibit 99.1 and hereby incorporated in this Item 7.01 by reference.

The information in this Item 7.01 of this Current Report on Form 8-K and the press release shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (as amended, the "Exchange Act") or otherwise subject to the liabilities of that Section, and shall not be or be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

© Edgar Online, source Glimpses